Revenue
211 million USD
2026 Q3 · USD
Exact inputs and evidence
- Revenue: 211030000 USD Source
Fundies. English
Glaukos Corporation
EDGARAnnual consolidated revenue for 2025: about USD 507.4M, using the latest reported figures. The previous period, 2024, was about USD 383.5M.
Latest quarter
Operating margin
0.39%
2026 Q3 · %
Operating cash flow
38.6 million USD
2026 Q3 · USD
Free cash flow
36.5 million USD
2026 Q3 · USD
- Cash and cash equivalents
- 162 million USD Source
Exact value
162327000 USD
- Long-term debt including current maturities
- 3.04 million Unit12 Source
Exact value
3039000 Unit12
- Shares outstanding
- 59.2 million shares Source
Exact value
59168000 shares
Includes later revisions to earlier periods. Annual charts exclude incomplete years.
Latest filing recorded: 2026-10-28.
Financial data available through: 2025-12-31.
Coverage by financial measure
- Revenue: 3 of 11 periods available· newest 2025-12-31
- Operating income: 3 of 11 periods available· newest 2025-12-31
- Net income: 3 of 11 periods available· newest 2025-12-31
- Operating cash flow: 3 of 11 periods available· newest 2025-12-31
- Capital expenditure: 3 of 11 periods available· newest 2025-12-31
- Total assets: 2 of 11 periods available· newest 2025-12-31
- Total liabilities: 2 of 11 periods available· newest 2025-12-31
- Current assets: 2 of 11 periods available· newest 2025-12-31
- Current liabilities: 2 of 11 periods available· newest 2025-12-31
- Cash and cash equivalents: 3 of 11 periods available· newest 2025-12-31
- Long-term debt including current maturities: 1 of 11 periods available· newest 2015-12-31
- Shares outstanding: 2 of 11 periods available· newest 2025-12-31
Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.
What changed year over year
Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.
Revenue
+32.3%Prior period
USD 383.48 million
–
Current period
USD 507.44 million
–
Exact inputs and evidence
507442000 − 383481000 = 123961000 USD
383481000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source507442000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current sourceShare or cite
The citation records this snapshot. The page link may show a newer release later.
Net income
−USD 41.33 millionPrior period
−USD 146.37 million
–
Current period
−USD 187.7 million
–
Exact inputs and evidence
-187700000 − -146372000 = -41328000 USD
-146372000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source-187700000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current sourceShare or cite
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+USD 46.52 millionPrior period
−USD 61.32 million
–
Current period
−USD 14.8 million
–
Exact inputs and evidence
-14800000 − -61318000 = 46518000 USD
-61318000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source-14800000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current sourceShare or cite
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
+21.7%Prior period
USD 6.3 million
–
Current period
USD 7.67 million
–
Exact inputs and evidence
7666000 − 6300000 = 1366000 USD
6300000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source7666000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current sourceShare or cite
The citation records this snapshot. The page link may show a newer release later.
Where revenue goes
How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.
2025 2025-01-01 – 2025-12-31
- Revenue USD 507.44 million 100% of revenue
- Cost of revenue USD 111.81 million 22% of revenue
- Operating expenses USD 482.36 million 95% of revenue
- Other operating costs Derived USD 112.87 million 22% of revenue
- Operating income −USD 199.6 million −39% of revenue
- Tax, interest and other Derived −USD 11.9 million −2.3% of revenue
- Net income −USD 187.7 million −37% of revenue
Cash
- Operating cash flow −USD 14.8 million −2.9% of revenue
- Capital expenditure USD 7.67 million 1.5% of revenue
- Free cash flow Derived −USD 22.47 million −4.4% of revenue
Share of revenue by period
- Net income
- Tax, interest and other
- Operating costs
- 2023 Operating loss: operating costs were 141% of revenue.
- 2024 Operating loss: operating costs were 132% of revenue.
- 2025 Operating loss: operating costs were 139% of revenue.
Values and sources
| Period | Revenue | Operating costs | Operating income | Tax, interest and other | Net income | Free cash flow | Source |
|---|---|---|---|---|---|---|---|
| 2023 2023-01-01 – 2023-12-31 | 314711000 | 443411000 Derived | -128700000 | 5961000 Derived | -134661000 | -78006000 Derived | Source
|
| 2024 2024-01-01 – 2024-12-31 | 383481000 | 505847000 Derived | -122366000 | 24006000 Derived | -146372000 | -67618000 Derived | Source
|
| 2025 2025-01-01 – 2025-12-31 | 507442000 | 707042000 Derived | -199600000 | -11900000 Derived | -187700000 | -22466000 Derived | Source
|
Amounts are exact, in USD.
Growth
Sales over time and how quickly they are changing.
Revenue
Revenue reported for each complete financial period.
USD 507.4M 2025
Values and sources
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2023 | Revenue | 314711000 |
|
| 2024 | Revenue | 383481000 |
|
| 2025 | Revenue | 507442000 |
|
Revenue growth
Change in revenue from the same financial period one year earlier.
32.3% 2025
Values and sources
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2023 | Year over year | No prior comparable period |
|
| 2024 | Year over year | 21.9% |
|
| 2025 | Year over year | 32.3% |
|
Profit and cash
How much revenue becomes profit, and how much cash operations generate.
Profit margins
Operating income, net income and free cash flow as a share of revenue.
Operating margin -39.3% 2025
Net margin -37% 2025
Free cash flow margin -4.4% 2025
- Operating margin
- Net margin
- Free cash flow margin
Values and sources
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2023 | Operating margin | -40.9% |
|
| 2024 | Operating margin | -31.9% |
|
| 2025 | Operating margin | -39.3% |
|
| 2023 | Net margin | -42.8% |
|
| 2024 | Net margin | -38.2% |
|
| 2025 | Net margin | -37% |
|
| 2023 | Free cash flow margin | -24.8% |
|
| 2024 | Free cash flow margin | -17.6% |
|
| 2025 | Free cash flow margin | -4.4% |
|
Operating cash flow
Cash generated by the company’s normal business operations.
USD -14.8M 2025
Values and sources
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2023 | Operating cash flow | -57758000 |
|
| 2024 | Operating cash flow | -61318000 |
|
| 2025 | Operating cash flow | -14800000 |
|
Free cash flow
Operating cash flow minus capital expenditure for the same period and unit.
USD -22.5M 2025
Values and sources
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2023 | Free cash flow | -78006000 |
|
| 2024 | Free cash flow | -67618000 |
|
| 2025 | Free cash flow | -22466000 |
|
Balance sheet
Liabilities and short-term ability to meet obligations at each period end.
Liabilities to assets
Total liabilities as a share of total assets.
26.6% 2025
Values and sources
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2023-12-31 | Liabilities / assets | Not reported | No source recorded |
| 2024 | Liabilities / assets | 21.3% |
|
| 2025 | Liabilities / assets | 26.6% |
|
Current assets to current liabilities
Current assets divided by current liabilities.
4.69× 2025
Values and sources
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2023-12-31 | Current assets / current liabilities | Not reported | No source recorded |
| 2024 | Current assets / current liabilities | 5.99× |
|
| 2025 | Current assets / current liabilities | 4.69× |
|
Cash generation
Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.
| Period | Net income | Operating cash flow | Capital expenditure | Free cash flow |
|---|---|---|---|---|
| 2023 2023-01-01 – 2023-12-31 | −USD 134.66 million Exact valueExact value: -134661000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 57.76 million Exact valueExact value: -57758000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 20.25 million Exact valueExact value: 20248000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 78.01 million Calculation and evidence-57758000 − 20248000 USD Exact free cash flow: -78006000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2024 2024-01-01 – 2024-12-31 | −USD 146.37 million Exact valueExact value: -146372000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 61.32 million Exact valueExact value: -61318000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 6.3 million Exact valueExact value: 6300000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 67.62 million Calculation and evidence-61318000 − 6300000 USD Exact free cash flow: -67618000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2025 2025-01-01 – 2025-12-31 | −USD 187.7 million Exact valueExact value: -187700000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 14.8 million Exact valueExact value: -14800000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 7.67 million Exact valueExact value: 7666000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 22.47 million Calculation and evidence-14800000 − 7666000 USD Exact free cash flow: -22466000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.
Dataset coverage and company identifiers
Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.
117 filings · 7,130 latest values · 7,130 originally reported values
Dataset published . Source filing dates and reporting periods are shown separately.
Identifiers: 0001192448, 1192448, GKOS, edgar:1192448
Also known as GLAUKOS CORP, GLAUKOS Corp, Glaukos Corporation